Infectious morbidity by catheter type in neutropenic children with cancer

Pediatric Infectious Disease Journal

Volumn 33, Issue 3, 2014, Pages 263-266

  Orgel, Etan ^a,b,c   Ji, Lingyun ^b   Pastor, William ^d   Schore, Reuven J ^d,e  

^a MILLER CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CHILDHOOD MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ETHNICITY; FEMALE; HICKMAN CATHETER; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NEUTROPENIA; NEWBORN; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; TOTALLY IMPLANTABLE CATHETER; TREATMENT OUTCOME; TUNNELED EXTERNALIZED CATHETER; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION; COMPLICATION; DEVICES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INDWELLING CATHETER; NEOPLASMS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MORBIDITY; NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84887979272     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000060     Document Type: Article

References (28)

1. Rackoff WR, Ge J, Sather HN, et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 1999;21:260-267.
2. Mongelluzzo J, Mohamad Z, Ten Have TR, et al. Corticosteroids and mortality in children with bacterial meningitis. JAMA. 2008;299:2048-2055.
3. Tomlinson D, Mermel LA, Ethier MC, et al. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis. 2011;53:697-710.
4. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-Associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer. 2008;51:53-58.
5. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 2006;62:358-365.
6. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648-654.
7. Handrup MM, Møller JK, Frydenberg M, et al. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;55:309-313.
8. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168-1174.
9. Worth LJ, Seymour JF, Slavin MA. Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices. Support Care Cancer. 2009;17:811-818.
10. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81:1159-1171.
11. Samaras P, Dold S, Braun J, et al. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology. 2008;74:237-244.
12. Hengartner H, Berger C, Nadal D, et al. Port-A-Cath infections in children with cancer. Eur J Cancer. 2004;40:2452-2458.
13. Matsuzaki A, Suminoe A, Koga Y, et al. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14:153-160.
14. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement. J Clin Oncol. 2005;23:3024-3029.
15. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005;128:489-495.
16. Loh AH, Chui CH. Port-A-Cath insertions in acute leukaemia and childhood malignancies. Asian J Surg. 2007;30:193-199.
17. Shen G, Gao Y, Wang Y, et al. Survey of the long-term use of peripherally inserted central venous catheters in children with cancer: experience in a developing country. J Pediatr Hematol Oncol. 2009;31:489-492.
18. Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51:251-255.
19. Penel N, Neu JC, Clisant S, et al. Risk factors for early catheter-related infections in cancer patients. Cancer. 2007;110:1586-1592.
20. Chang L, Tsai JS, Huang SJ, et al. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control. 2003;31:34-39.
21. Peynircioglu B, Canyigit M, Ergun O, et al. Radiologically placed venous ports in children. J Vasc Interv Radiol. 2007;18:1389-1394.
22. Nosher JL, Bodner LJ, Ettinger LJ, et al. Radiologic placement of a low profile implantable venous access port in a pediatric population. Cardiovasc Intervent Radiol. 2001;24:395-399.
23. Munro FD, Gillett PM, Wratten JC, et al. Totally implantable central venous access devices for paediatric oncology patients. Med Pediatr Oncol. 1999;33:377-381.
24. Platzbecker U, Illmer T, Schaich M, et al. Double lumen port access in patients receiving allogeneic blood stem cell transplantation. Bone Marrow Transplant. 2001;28:1067-1072.
25. Biffi R, Pozzi S, Agazzi A, et al. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol. 2004;15:296-300.
26. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002;100:1957-1964.
27. Burkhardt B, Zimmermann M, Oschlies I, et al.; BFM Group. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131:39-49.
28. Athale U, Siciliano S, Thabane L, et al. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer. 2008;51:792-797.